Literature DB >> 22417840

Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection.

Philippe Sosner1, Marc Wangermez, Carine Chagneau-Derrode, Gwenaël Le Moal, Christine Silvain.   

Abstract

BACKGROUND: The influence of hepatitis C virus (HCV) infection on atherosclerosis risk in HIV-infected patients has not been adequately evaluated in real-life situations. OBJECTIVES AND METHODS: We compared indexes of early atherosclerosis evaluated by echo-Doppler ultrasound (presence of plaque in carotid or femoral arteries) in 18 HCV-HIV co-infected patients versus 22 HIV mono-infected patients.
RESULTS: Prevalence of subclinical carotid plaque was significantly higher in HCV-HIV co-infected patients (p=0.04), despite of the fact LDL-cholesterol and blood pressure (BP) were lower in the co-infected patients (p=0.003). HCV chronic infection (OR=10; IC: 1.5-72; p=0.02) was an independent risk factor.
CONCLUSION: This cross sectional study suggests that HCV infection might be an independent cardiovascular risk factor in HCV-HIV co-infected patients. HCV infection might be considered as not only a liver infection but also as a metabolic disease in HIV patients, justifying regular cardiovascular surveillance.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22417840     DOI: 10.1016/j.atherosclerosis.2012.02.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  19 in total

Review 1.  Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.

Authors:  Susanna Naggie
Journal:  Top Antivir Med       Date:  2017 Feb/Mar

2.  Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.

Authors:  Kara W Chew; Debika Bhattacharya; Kathleen A McGinnis; Tamara B Horwich; Chi-Hong Tseng; Judith S Currier; Adeel A Butt
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-11       Impact factor: 2.205

Review 3.  Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients.

Authors:  Roger Bedimo; Oladapo Abodunde
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

Review 4.  Extrahepatic manifestations of chronic hepatitis C virus infection.

Authors:  Patrice Cacoub; Cloe Comarmond; Fanny Domont; Léa Savey; Anne C Desbois; David Saadoun
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 5.  HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.

Authors:  Alison Kearns; Jennifer Gordon; Tricia H Burdo; Xuebin Qin
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

Review 6.  The hepatitis C virus infection as a systemic disease.

Authors:  Anna Linda Zignego; Laura Gragnani; Carlo Giannini; Giacomo Laffi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

7.  A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study.

Authors:  Rebeccah A McKibben; Sabina A Haberlen; Wendy S Post; Todd T Brown; Matthew Budoff; Mallory D Witt; Lawrence A Kingsley; Frank J Palella; Chloe L Thio; Eric C Seaberg
Journal:  J Infect Dis       Date:  2015-07-27       Impact factor: 5.226

Review 8.  Viral infection and atherosclerosis.

Authors:  Nima Hemmat; Amin Ebadi; Reza Badalzadeh; Mohammad Yousef Memar; Hossein Bannazadeh Baghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-05       Impact factor: 3.267

Review 9.  Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

Authors:  Luigi E Adinolfi; Rosa Zampino; Luciano Restivo; Amedeo Lonardo; Barbara Guerrera; Aldo Marrone; Fabio Nascimbeni; Anna Florio; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

10.  HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection.

Authors:  Amber L Wheeler; Rebecca Scherzer; Daniel Lee; Joseph A C Delaney; Peter Bacchetti; Michael G Shlipak; Stephen Sidney; Carl Grunfeld; Phyllis C Tien
Journal:  AIDS       Date:  2014-01-02       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.